📍 Spreespeicher Grande Room, Stralauerstrasse 2A, Berlin
🕒 October 18, 2025 | 20:45–21:30 CEST
💬 Panel: Inside Out – Breakthroughs in Intratumoral Approaches
🌐 https://intoberlin.splashthat.com/
This evening, Robert Aleksandrowicz, CEO of Cellis, will participate in the Johnson & Johnson Innovation panel “Inside Out: Breakthroughs in Intratumoral Approaches,” held within the Johnson & Johnson Interventional Oncology (INTO) series.
The discussion will gather distinguished experts, clinicians, and biotechnology leaders to explore how intratumoral oncology—the precise delivery of therapies directly into tumor tissue—can complement and enhance systemic treatments. By combining local intervention with immune activation and targeted delivery, this approach seeks to reshape the way solid tumors are treated.
Representing Cellis, Robert Aleksandrowicz will share the company’s experience in developing macrophage-based therapeutic platforms designed to act at the tumor site while engaging the broader immune response. His perspective will highlight how translational research, strong scientific partnerships, and early industrial collaboration can accelerate the transition of innovative oncology concepts from the laboratory to the clinic.
We are honored that Cellis has been invited to contribute to this important dialogue on the future of precision and intratumoral oncology, and we look forward to exchanging ideas with leading innovators from across the global cancer research community.
